Bonesupport - Articles and news items

Bonesupport enrols first patient in injectable bone graft substitute trial

Industry news / 22 May 2017 / Niamh Marriott, Junior Editor

Bonesupport, the Scandinavian medical technology company, has enrolled their first patient at the University of Texas Health Science Center at San Antonio into the company’s pivotal Investigational Device Exemption (IDE) trial. Cerament G is an injectable antibiotic-eluting bone graft substitute that has proven remodelling capabilities and provides local sustained delivery of gentamicin. The data from […]

Osteomyelitis: How artificial bone grafts are filling the gap

Blog, Z Homepage promo / 17 November 2016 / Niamh Louise Marriott, Digital Content Producer

We caught up with Bonesupport’s CEO Richard Davies to find out how they’re using artificial bone grafts to help sufferers of chronic osteomyelitis…

FDA approves IDE study for bone graft substitute, Cerament G

Industry news / 10 August 2016 / Niamh Louise Marriott, Digital Content Producer

Bonesupport’s Fortify study will evaluate the safety and efficacy of Cerament G as part of surgical repair of open diaphyseal tibial fractures. The trial will enrol up to 230 patients at up to 30 centres globally, with the aim of having at least 50% of the study data coming from US subjects…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+